
| VTE prevention toolkit launched A new toolkit entitled ‘Preventing Venous Thromboembolism in Hospital - A Toolkit for Assessing and Improving Clinical Practice in Trusts’ has been created and launched by Bayer Schering Pharma in partnership with Anticoagulation Europe, as a guide in assessing and improving clinical practice in the prevention of venous thromboembolism (VTE) in hospital. For further information or to request this Toolkit, please provide your details to Bayer Schering Pharma through the Thrombosis Adviser website.
Why a Thromboprophylaxis Service Assessment Toolkit? This toolkit has been developed in collaboration with a multidisciplinary team of NHS healthcare professionals and Trust managers to make life easier for anyone involved in providing, managing or commissioning VTE thromboprophylaxis. Whatever your role in the implementation or management of local VTE thromboprophylaxis, you should find a number of useful resources in this toolkit.
This process of improving local thromboprophylaxis is in line with the latest NHS Confederation briefing on reducing deaths from blood clots in hospitals1.
The resources in this toolkit should therefore help Trusts to achieve - and demonstrate - Toolkit Audience This toolkit is suitable for use by anyone who is involved in the provision, management and
SECTION 1 Introduction and Background Objective: An overview of VTE prevention, and advice on how to use the toolkit to enhance clinical practice in your Trust SECTION 2 Overview of Organisational Thromboprophylaxis Baseline Assessment Objective: Step-by-step guidance on how to assess your Trust's performance in terms of VTE risk assessment and thromboprophylaxis SECTION 3 The Organisational Thromboprophylaxis Assessment and Implementation Tool Objective: Practical advice and support on how to establish effective measures to prevent VTE in your Trust
Reference:
|
|
| Friday, March 5, 2010 |
|

